Effect of protein kinase Cbeta inhibition on renal hemodynamic function and urinary biomarkers in humans with type 1 diabetes: a pilot study.
about
Diabetic kidney disease: from physiology to therapeuticsEarly diabetic nephropathy in type 1 diabetes: new insightsImprovements in the Management of Diabetic NephropathyRenal hyperfiltration is a determinant of endothelial function responses to cyclooxygenase 2 inhibition in type 1 diabetes.Evolution of renal hyperfiltration and arterial stiffness from adolescence into early adulthood in type 1 diabetesRenal hyperfiltration related to diabetes mellitus and obesity in human disease.The renal effects of SGLT2 inhibitors and a mini-review of the literature.Pathophysiology of the diabetic kidney.The Gomez' equations and renal hemodynamic function in kidney disease research.Glomerular Hyperfiltration in Diabetes: Mechanisms, Clinical Significance, and Treatment.Effects of systemic inhibition of Rho kinase on blood pressure and renal haemodynamics in diabetic rats.Systemic hemodynamic function in humans with type 1 diabetes treated with protein kinase Cβ inhibition and renin-angiotensin system blockade: a pilot study.The effect of aliskiren on urinary cytokine/chemokine responses to clamped hyperglycaemia in type 1 diabetes.Activation of general control nonderepressible 2 kinase protects human glomerular endothelial cells from harmful high-glucose-induced molecular pathways.Dapagliflozin in Focal Segmental Glomerulosclerosis: A Combined Human-Rodent Pilot Study.Influence of sex on hyperfiltration in patients with uncomplicated type 1 diabetes.Renin-angiotensin-aldosterone system activation in long-standing type 1 diabetes.Ability of Cystatin C to detect changes in glomerular filtration rate after ACE inhibition in patients with uncomplicated type 1 diabetes.Urinary markers of renal inflammation in adolescents with Type 1 diabetes mellitus and normoalbuminuria
P2860
Q27021392-94F1C86C-8411-41D6-A26F-692426C984DDQ27021632-E4642D6E-B2EE-4B0D-8339-1E7B3267BD14Q28080717-48FC9776-85F3-46EF-8636-3355DB051BB2Q33873175-6F49374F-3365-4574-BA74-E66DA175CB50Q35123425-C1BC551E-A7E1-4FE1-9850-66DB8DD3D32BQ35673442-23EBFBD0-8A4E-4F45-8350-B39B8F68597CQ37632127-3D6BB092-34B8-4249-8237-044548DF3EACQ38111707-C46E2BDD-1ACA-4448-936E-8495FDDA7CF7Q38949048-759C3314-C3A1-43A0-8487-D94AD4E41913Q39112475-CD81432C-44F1-4F01-913A-4918D7BE9768Q41539692-A68FBB59-53D4-4C5B-AAE0-D8DA697D603DQ45141864-C537FB94-85F0-4CFF-837D-98EC3711E83CQ46210012-EAF43C69-D040-4F00-AB39-BBFEEBE603FCQ46510122-8292BE97-581F-49E7-9A1C-E1695CDAD9BFQ47398861-B09C9B96-BDF9-4839-A3F9-A40326EC6C97Q47905741-AF222ED4-AC8D-4637-ADB7-B48C81A4D76EQ50101784-DC468452-5962-40E5-BF36-27F0149DD56CQ51356367-6806FAB6-8EEE-4969-AD37-501C584D5168Q58811129-782F080F-2FCC-49AC-BB84-209D646A5F4D
P2860
Effect of protein kinase Cbeta inhibition on renal hemodynamic function and urinary biomarkers in humans with type 1 diabetes: a pilot study.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 22 October 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Effect of protein kinase Cbeta ...... ype 1 diabetes: a pilot study.
@en
Effect of protein kinase Cbeta ...... ype 1 diabetes: a pilot study.
@nl
type
label
Effect of protein kinase Cbeta ...... ype 1 diabetes: a pilot study.
@en
Effect of protein kinase Cbeta ...... ype 1 diabetes: a pilot study.
@nl
prefLabel
Effect of protein kinase Cbeta ...... ype 1 diabetes: a pilot study.
@en
Effect of protein kinase Cbeta ...... ype 1 diabetes: a pilot study.
@nl
P2093
P2860
P50
P921
P356
P1433
P1476
Effect of protein kinase Cbeta ...... ype 1 diabetes: a pilot study.
@en
P2093
Anton Soosaipillai
David Z I Cherney
Heather Reich
James W Scholey
Joanne Lorraine
Judith A Miller
P2860
P356
10.2337/DC08-1609
P407
P577
2008-10-22T00:00:00Z